Present full SPEARHEAD-1 update at CTOS
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Nov 2021
- Delivered
- November 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“November: full update at Connective Tissue Oncology Society (CTOS)”
What we found
Evidence strength A What the grades mean
A 10-K filed March 2022 states that clinical data was presented at CTOS in November 2021, reporting a 34% ORR; the exact day is not given.
-
A Adaptimmune Therapeutics plc 10-K filed 2022-03-14
“Clinical data was presented at the Connective Tissue Oncology Society (“CTOS”) in November 2021. An Overall Response Rate (ORR) per independent review of 34% (36% in patients with synovial sarcoma and 25% for patients with MRCLS) and disease control rate of 85% was reported.” ✓ confirmed on the page
-
A Adaptimmune Therapeutics plc 8-K filed 2022-03-14
“As of the data cut-off of September 1, 2021 (CTOS), the overall response rate (ORR) per Independent Review was 34%” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
- Deliverable
- Full SPEARHEAD-1 data update at CTOS
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: subject to congress acceptance
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Adaptimmune Therapeutics plc? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ADAPY-024588 · Corrections policy